Royal Bank of Canada’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-5,500
Closed -$402K 7066
2024
Q3
$402K Hold
5,500
﹤0.01% 4271
2024
Q2
$369K Hold
5,500
﹤0.01% 4251
2024
Q1
$149K Buy
+5,500
New +$154K ﹤0.01% 4930

Other funds holding INSM

Royal Bank of Canada's INSM Position: Q1 2026 in Review

Royal Bank of Canada increased its Insmed (INSM) stake by 3.2% in Q1 2026, buying an estimated $2.5M and bringing the position to 523,101 shares worth $85.5M. The position accounts for 0.02% of the portfolio, ranked #692.

Royal Bank of Canada first reported a position in INSM in Q2 2013 and has held it in 50 quarters since. The position peaked at $195M in Q3 2025. 673 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Royal Bank of Canada held 523,101 shares of Insmed worth $85.5M as of Q1 2026.
  • Royal Bank of Canada bought 16,290 Insmed shares in Q1 2026, an estimated $2.5M.
  • Insmed made up 0.02% of Royal Bank of Canada's portfolio in Q1 2026, its #692 holding.
  • Royal Bank of Canada first reported a position in Insmed in Q2 2013 and has held it in 50 quarters since.
  • Royal Bank of Canada's Insmed position peaked at $195M in Q3 2025.
  • 673 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.